Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Multiple Myeloma”

356 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 356 results

Testing effectiveness (Phase 2)Study completedNCT01936532
What this trial is testing

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Who this might be right for
Newly Diagnosed Multiple Myeloma
Nantes University Hospital 42
Not applicableLooking for participantsNCT07087964
What this trial is testing

Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Newly Diagnosed Multiple Myeloma (NDMM)
Universiteit Antwerpen 120
Testing effectiveness (Phase 2)Study completedNCT00566098
What this trial is testing

Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Large-scale testing (Phase 3)Looking for participantsNCT05827016
What this trial is testing

Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 1,216
Testing effectiveness (Phase 2)Study completedNCT01402284
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT01718743
What this trial is testing

Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Hematopoietic Cell Transplantation RecipientPlasma Cell Myeloma
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)WithdrawnNCT03785184
What this trial is testing

Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy

Who this might be right for
Multiple Myeloma
AbbVie
Testing effectiveness (Phase 2)Ended earlyNCT01729338
What this trial is testing

Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Duke University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04782687
What this trial is testing

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaMyeloma MultipleKahler Disease+4 more
US Oncology Research 73
Testing effectiveness (Phase 2)Looking for participantsNCT02343042
What this trial is testing

Selinexor and Backbone Treatments of Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc 300
Testing effectiveness (Phase 2)UnknownNCT03809780
What this trial is testing

Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone

Who this might be right for
Multiple Myeloma
Kosin University Gospel Hospital 70
Testing effectiveness (Phase 2)Looking for participantsNCT05280275
What this trial is testing

Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible

Who this might be right for
Multiple MyelomaNeoplasmsNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 36
Post-approval studies (Phase 4)WithdrawnNCT04348006
What this trial is testing

Assessment of Bortezomib (Alvocade ®) Efficacy and Safety in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Newly Diagnosed Multiple Myeloma
Al-Rasheed University College
Testing effectiveness (Phase 2)Active Not RecruitingNCT06169215
What this trial is testing

Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 70
Early research (Phase 1)Study completedNCT01980589
What this trial is testing

A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects

Who this might be right for
Multiple Myeloma
Amgen 22
Post-approval studies (Phase 4)Ended earlyNCT02773550
What this trial is testing

Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Basque Health Service 24
Testing effectiveness (Phase 2)Study completedNCT02224729
What this trial is testing

Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Sidney Kimmel Cancer Center at Thomas Jefferson University 24
Large-scale testing (Phase 3)Study completedNCT02495922
What this trial is testing

A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma

Who this might be right for
Multiple Myeloma
University of Heidelberg Medical Center 564
Testing effectiveness (Phase 2)Study completedNCT02874742
What this trial is testing

Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 224
Testing effectiveness (Phase 2)Looking for participantsNCT07169500
What this trial is testing

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of Young NDMM

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 50
Load More Results